Characterization and Thermodynamic Stability of Polymorphs of Di(arylamino) Aryl Compound ASP3026-Reference-Cited by-同舟云学术

Characterization and Thermodynamic Stability of Polymorphs of Di(arylamino) Aryl Compound ASP3026

Published:2015 Issue:6 Volume:63 Page:418-422
ISSN:0009-2363
Container-title:Chemical and Pharmaceutical Bulletin
language:en
Short-container-title:CHEMICAL & PHARMACEUTICAL BULLETIN

Author:

Takeguchi Kazuhiro¹²,Hirakura Yutaka³,Yamazaki Kouji⁴,Shimada Itsuro⁵,Ieda Shigeru⁶,Okada Minoru²,Takiyama Hiroshi¹

Affiliation:

1. Department of Chemical Engineering, Tokyo University of Agriculture and Technology

2. Technology Process Chemistry Labs., Astellas Pharma Inc.

3. Technology Analytical Research Labs., Astellas Pharma Inc.

4. Drug Discovery Research Analysis & Pharmacokinetics Research Labs., Astellas Pharma Inc.

5. Drug Discovery Research Medicinal Chemistry Research Labs., Astellas Pharma Inc.

6. Astellas Pharma Tech Co., Ltd.

Publisher

Pharmaceutical Society of Japan

Subject

Drug Discovery,General Chemistry,General Medicine

Link

https://www.jstage.jst.go.jp/article/cpb/63/6/63_c14-00774/_pdf

Reference13 articles.

1. 1) Kondoh Y., Hkubo K., Kuromitsu S., Shindo N., Soga T., Furutani T., Shimada I., Matsuya T., Kurosawa K., Kamikawa A., Mano H., PCT Int. Appl., WO2009008371 A1 (2009).

2. 2) Shimada I., Hirakura Y., Yamazaki K., Takeguchi K., Ueda N., PCT Int. Appl., WO2011145548 A1 (2011).

3. 3) Datta S., Grant D., Nat. Rev. Drug Discov., 3, 42–57 (2004).

4. 4) Borka L., Haleblian J., Act. Pharm. Jigosl., 40, 71–94 (1990).

5. 5) Haleblian J., McCrone W., J. Pharm. Sci., 58, 911–929 (1969).

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nucleation control and separation of ethyl maltol polymorphs under different growth conditions through solution crystallization process in selected solvent environments;CrystEngComm;2024

2. Impurities Assisted with Control of Polymorphs during Seeded Crystallization;JOURNAL OF CHEMICAL ENGINEERING OF JAPAN;2020-04-20

3. Improved Manufacturing Route and Polymorphic Control of a Potent and Selective Anaplastic Lymphoma Kinase (ALK) Inhibitor ASP3026;Organic Process Research & Development;2019-02-20

4. Polymorphism of spironolactone: An unprecedented case of monotropy turning to enantiotropy with a huge difference in the melting temperatures;International Journal of Pharmaceutics;2018-12

5. Effect of Temperature and Solvent of Solvent-Mediated Polymorph Transformation on ASP3026 Polymorphs and Scale-up;Organic Process Research & Development;2016-04-28